Johnson & Johnson’s COVID-19 Vaccine Suspended After Blood Disorder Reports

Johnson & Johnson’s COVID-19 Vaccine  Suspended After Blood Disorder Reports

A manufacturing plant in Baltimore, Maryland where two experimental COVID-19 vaccines are manufactured has caused the U.S. Food and Drug Administration (FDA) to delay authorization of the plant’s production lines due to the contamination of 15 million doses of Johnson & Johnson’s (J&J) COVID-19 vaccine.1 Ingredients Used in Two COVID-19 Vaccines “Mixed Up” During Production […]

Dentists, Optometrists, Podiatrists Can Now Administer COVID-19 Vaccines in the U.S.

Dentists, Optometrists, Podiatrists Can Now Administer COVID-19 Vaccines in the U.S.

The U.S. Department of Health and Human Services (HHS) has announced that the agency is amending an emergency declaration under the Public Readiness and Emergency Preparedness Act (PREP Act) to authorize additional medical professionals to administer experimental COVID-19 vaccines being distributed under an Emergency Use Authorization (EUA).1 2 This announcement was made after President Biden […]

So What Happens if You Get Injured by a COVID-19 Vaccine?

So What Happens if You Get Injured by a COVID-19 Vaccine?

Opinion | The experimental COVID-19 vaccines are being released first to a designated group of health care workers and residents of senior living facilities. As more of the vaccines becomes available, people at high-risk to the SARS-CoV-2 virus due to their medical conditions will be given an opportunity to get vaccines. Finally, the general public […]

Over 3,000 “Health Impact Events” After COVID-19 mRNA Vaccinations

Over 3,000 “Health Impact Events” After COVID-19 mRNA Vaccinations

Between Dec. 11 and 18, 2020, the U.S. Food and Drug Administration (FDA) granted Pfizer/BioNTech and Moderna pharmaceutical companies an Emergency Use Authorization (EUA)1 to distribute COVID-19 vaccines using messenger RNA (mRNA) technology that to date has not been licensed for use in humans.2 3 4 5 Although the Advisory Committee on Immunization Practices (ACIP) […]

Government Proposes Making It Harder to Get Vaccine Injury Compensation

Government Proposes Making It Harder to Get Vaccine Injury Compensation

In July 2020, the U.S. Department of Health and Human Services (HHS) published a notice of proposed rule making in the Federal Register1 that would remove shoulder injuries and vasovagal syncope from the Vaccine Injury Table used by the National Vaccine Injury Compensation Program (NVICP). The proposed rule making would also eliminate Item XVII, whereby […]

Another Shot at a Vaccine for Lyme Disease

Another Shot at a Vaccine for Lyme Disease

The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland College of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources and Matthias Schnell, PhD, director […]

CureVac’s COVID-19 Vaccine Produces Grade 3 Adverse Events

CureVac’s COVID-19 Vaccine Produces Grade 3 Adverse Events

Biopharmaceutical company CureVac NV of Tübingen, Germany has released the interim results of its Phase 1 clinical trial on its experimental CVnCoV vaccine COVID-19. The vaccine, which was given to more than 250 healthy adults 18 to 60 years of age, is based on messenger ribonucleic acid (mRNA) technology.1 2 Unlike traditional vaccines, mRNA vaccines […]

CDC Gives States COVID-19 Vaccination Program “Playbook”

CDC Gives States COVID-19 Vaccination Program “Playbook”

The U.S. Centers for Disease Control (CDC) created a national COVID-19 Vaccine Program Playbook for state, territorial and local public health officials and their partners and issued directions for how to plan and operationalize COVID-19 vaccine programs in their jurisdictions. State health departments throughout the United States submitted comprehensive drafts of their COVID-19 vaccine distribution […]

Moderna’s COVID-19 Vaccine Provokes ‘COVID-Like Symptoms’ in Phase 3 Trial

Moderna’s COVID-19 Vaccine Provokes ‘COVID-Like Symptoms’ in Phase 3 Trial

Biotechnology firm Moderna, Inc. of Cambridge, Massachusetts began a Phase 3 human clinical trial to test the safety and efficacy of its experimental mRNA-1273 COVID-19 vaccine on July 27, 2020. The randomized, placebo-controlled trial involves giving two 100-microgram doses of the vaccine to 28,618 volunteer participants over 18 years of age, including some elderly people […]

1 2 3